JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, Y.
Right arrow Articles by Kellar, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, Y.
Right arrow Articles by Kellar, K. J.

Vol. 299, Issue 1, 366-371, October 2001

Blockade of Rat alpha 3beta 4 Nicotinic Receptor Function by Methadone, Its Metabolites, and Structural Analogs

Yingxian Xiao, Richard D. Smith, Frank S. Caruso and Kenneth J. Kellar

Department of Pharmacology, Georgetown University School of Medicine, Washington, DC (Y.X., K.J.K.); and Endo Pharmaceuticals, Inc., Neptune, New Jersey (R.S.-C., F.S.C.)

The opioid agonist properties of (±)-methadone are ascribed almost entirely to the (-)-methadone enantiomer. To extend our knowledge of the pharmacological actions of methadone at ligand-gated ion channels, we investigated the effects of the two enantiomers of methadone and its metabolites R-(+)-2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium perchlorate (EDDP) and R-(+)-2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline hydrochloride (EMDP), as well as structural analogs of methadone, including (-)-alpha -acetylmethadol hydrochloride (LAAM) and (+)-alpha -propoxyphene, on rat alpha 3beta 4 neuronal nicotinic acetylcholine receptors (nAChRs) stably expressed in a human embryonic kidney 293 cell line, designated KXalpha 3beta 4R2. (±)-Methadone inhibited nicotine-stimulated 86Rb+ efflux from the cells in a concentration-dependent manner with an IC50 value of 1.9 ± 0.2 µM, indicating that it is a potent nAChR antagonist. The (-)- and (+)-enantiomers of methadone have similar inhibitory potencies on nicotine-stimulated 86Rb+ efflux, with IC50 values of approximately 2 µM. EDDP, the major metabolite of methadone, is even more potent, with an IC50 value of approximately 0.5 µM, making it one of the most potent nicotinic receptor blockers reported. In the presence of (±)-methadone, EDDP, or LAAM, the maximum nicotine-stimulated 86Rb+ efflux was markedly decreased, but the EC50 value for nicotine stimulation was altered only slightly, if at all, indicating that these compounds block alpha 3beta 4 nicotinic receptor function by a noncompetitive mechanism. Consistent with a noncompetitive mechanism, (±)-methadone, its metabolites, and structural analogs have very low affinity for nicotinic receptor agonist binding sites in membrane homogenates from KXalpha 3beta 4R2 cells. We conclude that both enantiomers of methadone and its metabolites as well as LAAM and (+)-alpha -propoxyphene are potent noncompetitive antagonists of alpha 3beta 4 nAChRs.


0022-3565/01/2991-0366$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.